Statistics
Publications
3
Citations
273
H-Index
3
Active since
2022
Affiliations
Stefan Gajewski is an author at Nurix (United States) specializing in molecular oncology, oncology, and tyrosine kinase inhibitors.
Publications per year
2022–2024
3
3
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text
Daniel Robbins, Mark Noviski, Ying Siow Tan et al. · Journal of Medicinal Chemistry · 2024 · 96 citations · Full text
1–3 of 3